The company's SureSelect Human All Exon v8 provides content and the latest data covering protein coding regions from RefSeq, consensus coding sequence (CCDS), and GENCODE, as well as the TERT promoter and difficult to capture exons.

Finally, the new design is available in the following options:

• Routine exome sequencing (Exome v8)
• Clinical research sequencing (v8 Clinical Plus)
• Translational research (v8 UTR Plus)

Agilent reports revenue increase for Q2
Agilent Technologies saw revenue exceed expectations for the company's second quarter, while net income more than doubled.

Agilent debuts immune cell analysis platform
Agilent Technologies has debuted its Seahorse extracellular flux (XF) HS miniplate that provides improved immune cell metabolic analysis.

Agilent offers new flow cytometers
Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.

Agilent expands molecule manufacturing capacity
Agilent Technologies said that it's expanding its Frederick, CO-based production facility to more than double its current capacity for developing the...